Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ra Pharmaceuticals, Inc. | 0 | reported | 02 Apr 2020 | tx 66+433,117−620,774 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 14,492 | 48.00 USD | |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 10,416 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 133,000 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 62,500 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 90,000 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 11,110 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 73,654 | 0.00 USD | deriv |
| 16 Mar 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 5.60 USD | |
| 16 Mar 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 5.60 USD | |
| 16 Mar 2020 | SALE | Ra Pharmaceuticals, Inc. | 10,595 | 45.16 USD | |
| 16 Mar 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 0.00 USD | deriv |
| 16 Mar 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 0.00 USD | deriv |
| 18 Feb 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 5.60 USD | |
| 18 Feb 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 5.60 USD | |
| 18 Feb 2020 | SALE | Ra Pharmaceuticals, Inc. | 10,595 | 46.61 USD | |
| 18 Feb 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 0.00 USD | deriv |
| 18 Feb 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 0.00 USD | deriv |
| 15 Jan 2020 | SALE | Ra Pharmaceuticals, Inc. | 10,595 | 46.95 USD | |
| 15 Jan 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 5.60 USD | |
| 15 Jan 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 5.60 USD | |
| 15 Jan 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 0.00 USD | deriv |
| 15 Jan 2020 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 0.00 USD | deriv |
| 16 Dec 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,595 | 47.23 USD | |
| 16 Dec 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 1,389 | 5.60 USD | |
| 16 Dec 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 9,206 | 5.60 USD |